Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use CUTAQUIG safely and effectively. See full prescribing information for CUTAQUIG. CUTAQUIG® (Immune Globulin Subcutaneous (Human) - hipp), 16.5% solution Initial U.S. Approval: 2018
Medication labelWhy this: Advisory · dailymed-other
CUTAQUIG (Immune Globulin Subcutaneous (Human) - hipp) is a 16.5% immune globulin solution for subcutaneous infusion (IGSC), indicated as replacement therapy for primary humoral immunodeficiency (PI) in adults and pediatric patients 2 years of age and older. This includes, but is not limited to, common variable immunodeficiency (CVID), X-linked agammaglobulinemia, congenital agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies.
- generic_name
- immunoglobulin g
- product_names
- immunoglobulin G
- ndc
- 68982-810, 68982-810-81, 68982-810-01, 68982-810-82, 68982-810-02, 68982-810-83, 68982-810-03, 68982-810-84, 68982-810-04, 68982-810-85, 68982-810-05, 68982-810-86, 68982-810-06
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en